| 11:30 am |
Simultaneous Symposia: Session 3
In-person attendees can choose from three simultaneous symposia. One of the three symposia will be livestreamed for virtual attendees to view. All attendees will have access to on-demand recordings from each symposium following the conference.
Symposium 3A: Updates on CRC Screening and Surveillance
Moderator: Charles J. Kahi, MD, MSc, FACG
- At What Age Should I Start Screening and When Should I Stop?
Aasma Shaukat, MD, MPH, FACG
Review the evidence of more aggressive, earlier colorectal cancers to support clinical guidelines for screening.
- How to Inform Patient Screening Choice in the Context of COVID
Charles J. Kahi, MD, MSc, FACG
Define screening test characteristic performances for adenoma, advanced adenoma, and cancer by stage; and highlight shifts, barriers, and facilitators to high-quality screening during a pandemic.
- How to Incorporate the New CRC Surveillance Recommendations Into Practice
Samir Gupta, MD
Summarize post-polypectomy surveillance recommendations, including major changes from the prior recommendations, and outline evidence-based surveillance practices.
Symposium 3B: The Latest in the A-Zs of Acute Pancreatitis
Moderator: Linda S. Lee, MD
- Managing Acute Pancreatitis in the First 24 Hours
Bechien U. Wu, MD
Explain how to diagnose and risk stratify patients with acute pancreatitis, and identify key components in early management including fluids, diet, pain control, antibiotic use, and monitoring for compartment syndrome.
- Managing Complications of Acute Pancreatitis Including Leaks and Collections
Linda S. Lee, MD
Describe common complications of acute pancreatitis that can be managed endoscopically, including pseudocysts, walled-off necrosis and pancreatic duct leaks, and recognize optimal treatment approaches for these conditions.
- Idiopathic Recurrent Acute Pancreatitis: How to Evaluate and Manage
Darwin L. Conwell, MD, MS, FACG
Discuss work-up for diagnosing the etiology of idiopathic recurrent acute pancreatitis, and outline medical and endoscopic management.
Symposium 3C: Gastric Disorders: Burning Issues in 2021
Moderator: Colin W. Howden, MD, FACG
- Acid-Peptic Disorders: What’s New in 2021?
Colin W. Howden, MD, FACG
Identify new therapeutic options for acid-peptic disorders.
- Update in Gastroparesis and Functional Dyspepsia
Braden Kuo, MD
Explain medical and surgical therapies for motility and functional disorders of the stomach.
- Polyps and Nodules of the Stomach: When to Survey, Resect, or Refer for EUS
Saowanee Ngamruengphong, MD
Summarize the latest diagnostic and management approaches to polyps and nodules of the stomach.
|
| 5:10 pm |
Simultaneous Symposia: Session 4
In-person attendees can choose from three simultaneous symposia. One of the three symposia will be livestreamed for virtual attendees to view. All attendees will have access to on-demand recordings from each symposium following the conference.
Symposium 4A: Functional Esophageal Disorders: Managing Patients With Symptoms and Negative Testing
Moderator: Ronnie Fass, MD, FACG
- Functional Heartburn
Ronnie Fass, MD, FACG
Discuss the diagnosis of functional heartburn and options for management.
- Functional Chest Pain
John O. Clarke, MD, FACG
Review the approach to evaluation of non-cardiac chest pain, and the management of patients with chest pain and negative testing.
- Functional Dysphagia
Charlene Prather, MD, MPH
Describe the diagnostic approach and treatment options for functional dysphagia.
Symposium 4B: Conundrums of Pancreatobiliary Diseases
Moderator: Linda S. Lee, MD
- How Do I Get the Large Biliary Stone Out?
Harry R. Aslanian, MD, FACG
Describe how best to remove large biliary stones while minimizing risk of perforation and pancreatitis.
- Pancreatic Cyst Management 101
Linda S. Lee, MD
Discuss the different guidelines and how to approach pancreatic cyst management.
- 2021 Updates in Diagnosing and Managing Biliary Strictures: Is It Malignant or Not? Stent Both Sides or Not?
Phillip S. Ge, MD
Explain the advances in diagnosing indeterminate biliary strictures utilizing conventional techniques, FISH, DNA analysis, cholangioscopy, nCLE, and artificial intelligence; discuss how best to manage suspected hilar cholangiocarcinoma while avoiding potential pitfalls.
|
